维普期刊资源整合服务平台（V6.5）

225篇 您的检索式：作者名="Awada A"

选中清除导出查看参考文献查看引证文献引用追踪共12页首页上一页第1页下一页末页 /12 跳转

	题名	作者	年代	出处	被引量
1	Tuberculous spondylitis:analysis of 69 cases from saudi arabia显示文摘	Alothman A Memish Z A Awada A	2001	Spine2001，26，24：	1
2	Rates of TOPOⅡ-alpha and HER-2 gene amplification and expression in epithelial ovarian carcinoma显示文摘	Mano MS Awada A DiLeo A	2004	Gynecologic Oncology2004，92，6：	1
3	Obstetrical prognosis of the septate uterus:a plea for treatment of the septum显示文摘	Gaucherand P Awada A Rudigoz RC	1994	Eur J Obstet Gynecol Reprod Biol1994，54，：	1
4	Dietary phytosterol inhibits the growth and metastasis ofM DA-M B-231 human breast cancer cells grow in SCID mice 显示文摘	Awada B Downie A Fink C S	2000	Anticancer Research2000，20，2：	1
5	Pooled analysis of BAY 43-92006 (sorafenib) monotherapy in patients with advanced solid turnouts: is rash associated with treat- ment outcome? 显示文摘	Strumberg D Awada A Hirte H	2006	Eur J Cancer2006，42，4：	1
6	Phase Ⅰ trial of sorafenib and gemcitabine in advanced solid tumors with an expanded eohoa in advanced pancreatic cancer显示文摘	Siu LL Awada A Takimoto CH	2006	Clin Cancer Res2006，12，1：	1
7	Ecophysiological responsesof schizachyrium scoparium to water and nitrogen manipulations显示文摘	Kochsiek A Ciganda V Bryan N Hite L Awada T	2006	Great Plains Research2006，16，1：	1
8	Nontraumatic cerebral hemorrhage in the young: study of 107 cases 显示文摘	Awada A Daif A Obeid T	1998	J Stroke Cerebrovasc Dis1998，7，3：	1
9	The addition of cetuximab tocisplatin increases overall response rate (ORR) and progression-freesurvival (PFS) in metastatic triple-negative breast cancer (TNBC):results of a randmomised phase II study (BALI-1 ) 显示文摘	Baselga J G6mez P Awada A	2010	Ann Oncol2010，21，：	1
10	Milestones in the use of chemotherapy for the management of non-small cell lung cancer (NSCLC)显示文摘	KLASTERSKY J AWADA A	2012	Crit Rev Oneol Hematol2012，81，1：	1
11	Stroke and pregnancy显示文摘	Awada A Rajeh S Duarte R	1995	Int J Gyneal Obstet1995，48，1：	1
12	Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer显示文摘	Atalay G Cardoso F Awada A	2003	Ann Oncol2003，14，9：	1
13	Phase 2 results ofXL184in a cohort of patients(PTS)with advanced non-smallcell lung cancer(NSCLC)显示文摘	Yasenchak C Nackaerts K Awada A	2010	Ejc Supplements2010，8，7：	1
14	Elastography in the assessment of sentinel lymph nodes prior to dissection显示文摘	Tourasse C Denier JF Awada A	2012	Eur J Radiol2012，81，11：	1
15	Pooled safety analysis of BAY 43 - 9006 (sorafenib) monotherapy in patients with advanced solid tumours: Is rash associated with treatment outcome? 显示文摘	Strumberg D Awada A Hirte H	2006	Eur J Cancer2006，42，：	1
16	Clinical phase Ⅰpharmacokinetic study of S 16020,a new olivacine derivative:report on three infusion schedules 显示文摘	AWADA A GIACCHETTI S GERARD B	2002	Ann Oncol2002，13，12：	1
17	Safety, pharmacokinelics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refiactory solid tumors显示文摘	Strmnberg D Clark JW Awada A	2007	Oncologist2007，12，4：	1
18	Lapatinib monotherapy in patients with HER-2 overexpressing relapsed or refractory inflam- matory breast cancer: final results and survival of the expanded HER-2 + cohort in EGF103009 ,a phase II study显示文摘	Kaufman B Trudeau M Awada A	2009	Lancet On- col2009，10，：	1
19	Se- lected combination therapy with so- rafenib a review of clinical data and perspectives in advanced solid tumors显示文摘	Dallago L Dhondt V Awada A	2008	Oncologist2008，13，8：	1
20	Lapatinib monotherapy in patients with HER2 - overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2 + cohort in EGF 103009, a phase Ⅱ study 显示文摘	KAUFMAN B TRUDEAU M AWADA A	2009	Lancet Oncol2009，10，6：	1

返回顶部每页显示：

共12页首页上一页第1页下一页末页 /12 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示